Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine XR vs Paroxetine in Panic Disorder
NCT00195598Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of venlafaxine in panic disorder (2 arms), sponsored by Pfizer. Primary endpoint: Improvement in social function. Started Jan 2005; status: completed.
02
Drugs
venlafaxine
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00195598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195598.